Home › Funds › Spruce Street Capital LP › ANIX

Spruce Street Capital LP position in ANIX

KORSANA BIOSCIENCES INC · Health Care

Spruce Street Capital LP reported holding 338,951 shares of ANIX (KORSANA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 1.64% of its reported portfolio and ranking #19 among its reported holdings. Spruce Street Capital LP first reported this position in Q3 2026.

Latest position (Q3 2026)338.95K sh
Reported value held$10.30M
Portfolio Weight1.64%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's ANIX position evolved

Spruce Street Capital LP first disclosed a stake in ANIX in Q3 2026 at 338,951 shares (US$10.3M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 338.95K $10.30M New

About ANIX and 13F data

ANIX (KORSANA BIOSCIENCES INC) is a Health Care company. 39 other funds we track also report a position in ANIX — the largest reported positions include Sanofi (US$63.8M), Vivo Capital, LLC (US$28.1M), Remedium Capital Partners, LLC (US$16.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIX

All ANIX fund holders →

FAQ

How long has Spruce Street Capital LP held ANIX?

Spruce Street Capital LP has disclosed ANIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Spruce Street Capital LP's current position in ANIX?

As of Q3 2026, Spruce Street Capital LP holds 338.95K shares of ANIX (KORSANA BIOSCIENCES INC), valued at $10.30M, representing 1.64% of its reported portfolio and ranking #19.

Has Spruce Street Capital LP been buying or selling ANIX?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP newly opened its position in ANIX.

Which other funds hold ANIX?

Other major institutional holders of ANIX include Sanofi, Vivo Capital, LLC, Remedium Capital Partners, LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.